Inogen | INGN - Assets


Inogen reported $307.01M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 108.25B 968M Sep/2026
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 1.04B 29.85M Sep/2026
AtriCure USD 717.54M 40.89M Sep/2026
Baxter International USD 19.41B 377M Sep/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Boston Scientific USD 45.46B 245M Sep/2026
Cooper Companies USD 12.67B 191.1M Jun/2026
Dexcom USD 6.24B 216.5M Sep/2026
Edwards Lifesciences USD 14.14B 277.3M Sep/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.42B 250M Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Orthofix International USD 873.02M 13.58M Jun/2026
Philips EUR 26.7B 565M Jun/2026
ResMed USD 8.21B 754.14M Sep/2026
Steris USD 10.71B 22.5M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teleflex USD 6.35B 438.92M Sep/2026
X T L Biopharmaceuticals USD 166K 548K Dec/2025
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026